| Dr Lauren Ashley Coffey, PHD, LP | |
|
307 Conrad St, Rushville, NE 69360-6503 | |
| (308) 327-2026 | |
| (308) 327-2126 |
| Full Name | Dr Lauren Ashley Coffey |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 307 Conrad St, Rushville, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346764503 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 1036 (Nebraska) | Primary |
| Entity Name | Western Nebraska Behavioral Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073892675 PECOS PAC ID: 2466821145 Enrollment ID: O20221220002001 |
News Archive
Health law outreach efforts take on new wrinkles - Colorado officials launch controversial ads geared toward women and Enroll America changes how it tries to get people to sign up for health coverage. In the meantime, Republicans are releasing their own set of ads mocking the law.
In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. will give scientists at Washington University School of Medicine in St. Louis unprecedented access to information regarding more than 500 pharmaceuticals and pharmaceutical candidates in a partnership that focuses on discovering new uses for existing compounds.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today reported its financial results for its fiscal second quarter ended June 30, 2009. The Company reported revenues of $21,871, a 70% decrease over the same quarter of the prior year. The Company's order backlog at June 30, 2009 was $92,576 compared to nil at the end of the comparative quarter June 30, 2008.
immatics biotechnologies GmbH, a biopharmaceutical company developing rationally designed therapeutic vaccines that are active against cancer, announced today that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma (RCC). The trial has completed patient inclusion and it is expected that around 345 patients will be randomized across 10 countries in the US and Europe.
Using the Kessler Foundation Neglect Assessment Process (KF-NAP), Kessler researchers found a high rate of spatial neglect among inpatients with stroke. Affected patients had a higher risk for falls, longer lengths of stay and lesser likelihood of returning home after discharge.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lauren Ashley Coffey, PHD, LP Po Box 779, Rushville, NE 69360-0779 Ph: (308) 327-2026 | Dr Lauren Ashley Coffey, PHD, LP 307 Conrad St, Rushville, NE 69360-6503 Ph: (308) 327-2026 |
News Archive
Health law outreach efforts take on new wrinkles - Colorado officials launch controversial ads geared toward women and Enroll America changes how it tries to get people to sign up for health coverage. In the meantime, Republicans are releasing their own set of ads mocking the law.
In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. will give scientists at Washington University School of Medicine in St. Louis unprecedented access to information regarding more than 500 pharmaceuticals and pharmaceutical candidates in a partnership that focuses on discovering new uses for existing compounds.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today reported its financial results for its fiscal second quarter ended June 30, 2009. The Company reported revenues of $21,871, a 70% decrease over the same quarter of the prior year. The Company's order backlog at June 30, 2009 was $92,576 compared to nil at the end of the comparative quarter June 30, 2008.
immatics biotechnologies GmbH, a biopharmaceutical company developing rationally designed therapeutic vaccines that are active against cancer, announced today that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma (RCC). The trial has completed patient inclusion and it is expected that around 345 patients will be randomized across 10 countries in the US and Europe.
Using the Kessler Foundation Neglect Assessment Process (KF-NAP), Kessler researchers found a high rate of spatial neglect among inpatients with stroke. Affected patients had a higher risk for falls, longer lengths of stay and lesser likelihood of returning home after discharge.
› Verified 5 days ago
Catherine Jones-hazledine, Psychologist Medicare: Medicare Enrolled Practice Location: 307 Conrad St, Rushville, NE 69360 Phone: 308-327-2026 | |
Elissa Rosebraugh, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 307 Conrad St, Rushville, NE 69360 Phone: 308-299-0084 |